Department of Obstetrics and Gynaecology, 'Reina Sofía' University Hospital, Córdoba, Spain.
BJOG. 2012 Jun;119(7):795-9. doi: 10.1111/j.1471-0528.2012.03292.x. Epub 2012 Feb 23.
To analyse the short-, medium- and long-term complications in women undergoing hysteroscopic tubal sterilisation with the Essure(®) device.
Retrospective 7-year study.
Office hysteroscopic unit in a teaching hospital.
A total of 4306 women whoe underwent the Essure(®) sterilisation procedure from 2003 to 2010.
Data on the success of the procedure and complications arising from outpatient hysteroscopic sterilisation using the Essure(®) system were collected from consecutive women undergoing the procedure over a 7-year period.
Placement rate, successful bilateral tubal occlusion, perioperative adverse events, early postoperative (during the first 3 months of follow-up) and late complications (after the initial 3 months of follow-up).
A total of 4108 (96.8%) women completed the standard 3-month follow-up protocol. Only 534 (13%) women had undergone the procedure within the previous year. There were 115 (out of 4306; 2.7%) recorded complications, none of which resulted in the need for hospitalisation or discharge later than 2 hours after the procedure. Vasovagal syncope was the most frequently encountered adverse event, occurring in 85 (2.0%) of 4306 cases. In 19 cases, one device was expelled, with most expulsions (14 out of 19) being detected before or during the 3-month follow-up.
Outpatient hysteroscopic sterilisation using the Essure(®) system is safe, with a low rate of complications.
分析行宫腔镜输卵管绝育术的妇女在短期、中期和长期的并发症。
回顾性 7 年研究。
教学医院门诊宫腔镜室。
共 4306 名于 2003 年至 2010 年间行 Essure（®）绝育术的妇女。
收集连续接受 Essure（®）系统门诊宫腔镜绝育术的妇女在 7 年内的手术成功率和并发症数据。
放置率、双侧输卵管闭塞成功、围手术期不良事件、早期术后（随访前 3 个月内）和晚期并发症（随访初始 3 个月后）。
共 4108 名（96.8%）妇女完成了标准的 3 个月随访方案。仅有 534 名（13%）妇女在过去 1 年内接受了该手术。共记录到 115 例（4306 例中的 13%）并发症，无一例需要住院治疗或在手术后 2 小时内出院。血管迷走神经性晕厥是最常见的不良事件，发生在 4306 例中的 85 例（2.0%）。19 例中有 1 个器械被排出，其中大多数（14 例）在 3 个月随访前或随访期间被发现。
使用 Essure（®）系统行门诊宫腔镜绝育术安全，并发症发生率低。
